nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Anaphylactic shock—Etoposide—testicular cancer	0.000967	0.000967	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000962	0.000962	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—testicular cancer	0.000958	0.000958	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—testicular cancer	0.000956	0.000956	CcSEcCtD
Tobramycin—Asthma—Epirubicin—testicular cancer	0.000953	0.000953	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Tobramycin—Paraesthesia—Cisplatin—testicular cancer	0.000948	0.000948	CcSEcCtD
Tobramycin—Thrombocytopenia—Etoposide—testicular cancer	0.000947	0.000947	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000947	0.000947	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Tobramycin—Dyspnoea—Cisplatin—testicular cancer	0.000941	0.000941	CcSEcCtD
Tobramycin—Skin disorder—Etoposide—testicular cancer	0.000939	0.000939	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—testicular cancer	0.000935	0.000935	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Tobramycin—Anorexia—Etoposide—testicular cancer	0.000922	0.000922	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000919	0.000919	CcSEcCtD
Tobramycin—Decreased appetite—Cisplatin—testicular cancer	0.000917	0.000917	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—testicular cancer	0.000917	0.000917	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—testicular cancer	0.000914	0.000914	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000911	0.000911	CcSEcCtD
Tobramycin—Vomiting—Bleomycin—testicular cancer	0.000911	0.000911	CcSEcCtD
Tobramycin—Infestation NOS—Methotrexate—testicular cancer	0.000908	0.000908	CcSEcCtD
Tobramycin—Infestation—Methotrexate—testicular cancer	0.000908	0.000908	CcSEcCtD
Tobramycin—Rash—Bleomycin—testicular cancer	0.000903	0.000903	CcSEcCtD
Tobramycin—Pain—Cisplatin—testicular cancer	0.000903	0.000903	CcSEcCtD
Tobramycin—Dermatitis—Bleomycin—testicular cancer	0.000902	0.000902	CcSEcCtD
Tobramycin—Hypersensitivity—Ifosfamide—testicular cancer	0.000902	0.000902	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Tobramycin—Renal failure—Methotrexate—testicular cancer	0.000893	0.000893	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000886	0.000886	CcSEcCtD
Tobramycin—Stomatitis—Methotrexate—testicular cancer	0.000885	0.000885	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Tobramycin—Asthenia—Ifosfamide—testicular cancer	0.000878	0.000878	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—testicular cancer	0.000873	0.000873	CcSEcCtD
Tobramycin—Feeling abnormal—Cisplatin—testicular cancer	0.00087	0.00087	CcSEcCtD
Tobramycin—Paraesthesia—Etoposide—testicular cancer	0.000868	0.000868	CcSEcCtD
Tobramycin—Pruritus—Ifosfamide—testicular cancer	0.000866	0.000866	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—testicular cancer	0.000862	0.000862	CcSEcCtD
Tobramycin—Dyspnoea—Etoposide—testicular cancer	0.000862	0.000862	CcSEcCtD
Tobramycin—Epistaxis—Methotrexate—testicular cancer	0.000856	0.000856	CcSEcCtD
Tobramycin—Nausea—Bleomycin—testicular cancer	0.000851	0.000851	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—testicular cancer	0.00085	0.00085	CcSEcCtD
Tobramycin—Infestation—Epirubicin—testicular cancer	0.00085	0.00085	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—testicular cancer	0.000849	0.000849	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Tobramycin—Agranulocytosis—Methotrexate—testicular cancer	0.000847	0.000847	CcSEcCtD
Tobramycin—Rash—Dactinomycin—testicular cancer	0.000842	0.000842	CcSEcCtD
Tobramycin—Decreased appetite—Etoposide—testicular cancer	0.000841	0.000841	CcSEcCtD
Tobramycin—Diarrhoea—Ifosfamide—testicular cancer	0.000838	0.000838	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000835	0.000835	CcSEcCtD
Tobramycin—Body temperature increased—Cisplatin—testicular cancer	0.000834	0.000834	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000833	0.000833	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Tobramycin—Pain—Etoposide—testicular cancer	0.000827	0.000827	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Tobramycin—Dizziness—Ifosfamide—testicular cancer	0.00081	0.00081	CcSEcCtD
Tobramycin—Pharyngitis—Methotrexate—testicular cancer	0.000809	0.000809	CcSEcCtD
Tobramycin—Urinary tract disorder—Methotrexate—testicular cancer	0.000805	0.000805	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—testicular cancer	0.000802	0.000802	CcSEcCtD
Tobramycin—Urethral disorder—Methotrexate—testicular cancer	0.000799	0.000799	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—testicular cancer	0.000797	0.000797	CcSEcCtD
Tobramycin—Feeling abnormal—Etoposide—testicular cancer	0.000797	0.000797	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—testicular cancer	0.000794	0.000794	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—testicular cancer	0.000793	0.000793	CcSEcCtD
Tobramycin—Gastrointestinal pain—Etoposide—testicular cancer	0.000791	0.000791	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—testicular cancer	0.000786	0.000786	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—testicular cancer	0.000786	0.000786	CcSEcCtD
Tobramycin—Visual impairment—Methotrexate—testicular cancer	0.000786	0.000786	CcSEcCtD
Tobramycin—Vomiting—Ifosfamide—testicular cancer	0.000778	0.000778	CcSEcCtD
Tobramycin—Hypersensitivity—Cisplatin—testicular cancer	0.000778	0.000778	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—testicular cancer	0.000773	0.000773	CcSEcCtD
Tobramycin—Rash—Ifosfamide—testicular cancer	0.000772	0.000772	CcSEcCtD
Tobramycin—Dermatitis—Ifosfamide—testicular cancer	0.000771	0.000771	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000771	0.000771	CcSEcCtD
Tobramycin—Urticaria—Etoposide—testicular cancer	0.000768	0.000768	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—testicular cancer	0.000765	0.000765	CcSEcCtD
Tobramycin—Abdominal pain—Etoposide—testicular cancer	0.000764	0.000764	CcSEcCtD
Tobramycin—Body temperature increased—Etoposide—testicular cancer	0.000764	0.000764	CcSEcCtD
Tobramycin—Eye disorder—Methotrexate—testicular cancer	0.000762	0.000762	CcSEcCtD
Tobramycin—Tinnitus—Methotrexate—testicular cancer	0.00076	0.00076	CcSEcCtD
Tobramycin—Asthenia—Cisplatin—testicular cancer	0.000757	0.000757	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—testicular cancer	0.00075	0.00075	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—testicular cancer	0.000742	0.000742	CcSEcCtD
Tobramycin—Angiopathy—Methotrexate—testicular cancer	0.00074	0.00074	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—testicular cancer	0.000738	0.000738	CcSEcCtD
Tobramycin—Immune system disorder—Methotrexate—testicular cancer	0.000736	0.000736	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—testicular cancer	0.000735	0.000735	CcSEcCtD
Tobramycin—Mediastinal disorder—Methotrexate—testicular cancer	0.000735	0.000735	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Tobramycin—Nausea—Ifosfamide—testicular cancer	0.000727	0.000727	CcSEcCtD
Tobramycin—Diarrhoea—Cisplatin—testicular cancer	0.000722	0.000722	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Tobramycin—Hypersensitivity—Etoposide—testicular cancer	0.000712	0.000712	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Tobramycin—Erythema—Methotrexate—testicular cancer	0.00071	0.00071	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—testicular cancer	0.000708	0.000708	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—testicular cancer	0.000701	0.000701	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Tobramycin—Dysgeusia—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Tobramycin—Asthenia—Etoposide—testicular cancer	0.000694	0.000694	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000694	0.000694	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—testicular cancer	0.000692	0.000692	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—testicular cancer	0.000688	0.000688	CcSEcCtD
Tobramycin—Back pain—Methotrexate—testicular cancer	0.000686	0.000686	CcSEcCtD
Tobramycin—Pruritus—Etoposide—testicular cancer	0.000684	0.000684	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—testicular cancer	0.00068	0.00068	CcSEcCtD
Tobramycin—Vomiting—Cisplatin—testicular cancer	0.000671	0.000671	CcSEcCtD
Tobramycin—Vision blurred—Methotrexate—testicular cancer	0.000669	0.000669	CcSEcCtD
Tobramycin—Rash—Cisplatin—testicular cancer	0.000665	0.000665	CcSEcCtD
Tobramycin—Dermatitis—Cisplatin—testicular cancer	0.000665	0.000665	CcSEcCtD
Tobramycin—Erythema—Epirubicin—testicular cancer	0.000664	0.000664	CcSEcCtD
Tobramycin—Diarrhoea—Etoposide—testicular cancer	0.000662	0.000662	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Tobramycin—Ill-defined disorder—Methotrexate—testicular cancer	0.000658	0.000658	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—testicular cancer	0.000658	0.000658	CcSEcCtD
Tobramycin—Anaemia—Methotrexate—testicular cancer	0.000656	0.000656	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—testicular cancer	0.00065	0.00065	CcSEcCtD
Tobramycin—Back pain—Epirubicin—testicular cancer	0.000642	0.000642	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Tobramycin—Malaise—Methotrexate—testicular cancer	0.00064	0.00064	CcSEcCtD
Tobramycin—Dizziness—Etoposide—testicular cancer	0.000639	0.000639	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—testicular cancer	0.000638	0.000638	CcSEcCtD
Tobramycin—Vertigo—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Tobramycin—Leukopenia—Methotrexate—testicular cancer	0.000635	0.000635	CcSEcCtD
Tobramycin—Nausea—Cisplatin—testicular cancer	0.000627	0.000627	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Tobramycin—Cough—Methotrexate—testicular cancer	0.000619	0.000619	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Tobramycin—Vomiting—Etoposide—testicular cancer	0.000615	0.000615	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Tobramycin—Rash—Etoposide—testicular cancer	0.00061	0.00061	CcSEcCtD
Tobramycin—Dermatitis—Etoposide—testicular cancer	0.000609	0.000609	CcSEcCtD
Tobramycin—Headache—Etoposide—testicular cancer	0.000606	0.000606	CcSEcCtD
Tobramycin—Chest pain—Methotrexate—testicular cancer	0.000604	0.000604	CcSEcCtD
Tobramycin—Myalgia—Methotrexate—testicular cancer	0.000604	0.000604	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.0006	0.0006	CcSEcCtD
Tobramycin—Malaise—Epirubicin—testicular cancer	0.000599	0.000599	CcSEcCtD
Tobramycin—Discomfort—Methotrexate—testicular cancer	0.000597	0.000597	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Tobramycin—Confusional state—Methotrexate—testicular cancer	0.000584	0.000584	CcSEcCtD
Tobramycin—Cough—Epirubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Tobramycin—Anaphylactic shock—Methotrexate—testicular cancer	0.000579	0.000579	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—testicular cancer	0.000579	0.000579	CcSEcCtD
Tobramycin—Nausea—Etoposide—testicular cancer	0.000574	0.000574	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Tobramycin—Nervous system disorder—Methotrexate—testicular cancer	0.000568	0.000568	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Tobramycin—Thrombocytopenia—Methotrexate—testicular cancer	0.000567	0.000567	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—testicular cancer	0.000565	0.000565	CcSEcCtD
Tobramycin—Skin disorder—Methotrexate—testicular cancer	0.000563	0.000563	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Tobramycin—Anorexia—Methotrexate—testicular cancer	0.000552	0.000552	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Tobramycin—Cough—Doxorubicin—testicular cancer	0.000536	0.000536	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000528	0.000528	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—testicular cancer	0.000523	0.000523	CcSEcCtD
Tobramycin—Paraesthesia—Methotrexate—testicular cancer	0.00052	0.00052	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—testicular cancer	0.000517	0.000517	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—testicular cancer	0.000517	0.000517	CcSEcCtD
Tobramycin—Dyspnoea—Methotrexate—testicular cancer	0.000516	0.000516	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—testicular cancer	0.000506	0.000506	CcSEcCtD
Tobramycin—Decreased appetite—Methotrexate—testicular cancer	0.000503	0.000503	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.0005	0.0005	CcSEcCtD
Tobramycin—Pain—Methotrexate—testicular cancer	0.000495	0.000495	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000491	0.000491	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—testicular cancer	0.000487	0.000487	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Feeling abnormal—Methotrexate—testicular cancer	0.000477	0.000477	CcSEcCtD
Tobramycin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000474	0.000474	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Tobramycin—Pain—Epirubicin—testicular cancer	0.000463	0.000463	CcSEcCtD
Tobramycin—Urticaria—Methotrexate—testicular cancer	0.00046	0.00046	CcSEcCtD
Tobramycin—Abdominal pain—Methotrexate—testicular cancer	0.000458	0.000458	CcSEcCtD
Tobramycin—Body temperature increased—Methotrexate—testicular cancer	0.000458	0.000458	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Tobramycin—Pain—Doxorubicin—testicular cancer	0.000429	0.000429	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—testicular cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—testicular cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Hypersensitivity—Methotrexate—testicular cancer	0.000427	0.000427	CcSEcCtD
Tobramycin—Asthenia—Methotrexate—testicular cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Pruritus—Methotrexate—testicular cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Tobramycin—Diarrhoea—Methotrexate—testicular cancer	0.000396	0.000396	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Tobramycin—Dizziness—Methotrexate—testicular cancer	0.000383	0.000383	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Tobramycin—Vomiting—Methotrexate—testicular cancer	0.000368	0.000368	CcSEcCtD
Tobramycin—Rash—Methotrexate—testicular cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Dermatitis—Methotrexate—testicular cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Headache—Methotrexate—testicular cancer	0.000363	0.000363	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—testicular cancer	0.000358	0.000358	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Nausea—Methotrexate—testicular cancer	0.000344	0.000344	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Tobramycin—Rash—Epirubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Tobramycin—Headache—Epirubicin—testicular cancer	0.00034	0.00034	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Tobramycin—Nausea—Epirubicin—testicular cancer	0.000322	0.000322	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Rash—Doxorubicin—testicular cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—testicular cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Headache—Doxorubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—testicular cancer	0.000298	0.000298	CcSEcCtD
